Scientific Program

 

3rd UpDate on Hepatology Course, Bucharest 28th-29th April 2016

“Clinical Challenges, Unmet Needs and Emerging Therapies in Hepatology”

 The programme below is preliminary and will be updated regularly

28 April 2016

 8.00-9.45 Registration & Welcome

9.45-10.00 Introduction: Dan Dumitrascu, Liana Gheorghe

10.00-11.30 Managing Chronic Hepatitis B
Chair: Ferrucio Bonino, Mircea Diculescu

10.00-10.25 Personalized therapy of hepatitis B : current strategies
Pietro Lampertico, Milan, Italy

10.25-10.45 When to stop therapy with nucleos(t)ide analogues?
Dana Dobru, Targu Mures, Romania

10.45-11.05 Preventing long-term complications in hepatitis B:  impact of antiviral therapy
Joerg Petersen. Hamburg, Germany

11.05-11.30 Future perspectives of antiviral therapy in chronic hepatitis B
Maurizia Brunetto, Pisa, Italy

 

11.30-13.00 Update on autoimmune and cholestatic liver diseases
Chair: Anca Trifan, Liana Gheorghe

11.30-12.00 Update on autoimmune hepatitis and overlap syndrome
Vlad Ratziu, Paris, France

12.00-12.20 Update on primary sclerosing cholangitis: management and surveillance
Razvan Iacob, Bucharest, Romania

12.20-12.40 Update on primary biliary cirrhosis
Iulia Simionov, Bucharest, Romania

12.40-13.00 IgG4 cholangitis: current concepts
Andrada Seicean, Cluj-Napoca, Romania

13.00 – 14.00 Lunch 

14.00 – 14.45 Satellite Symposium BMS
Treatment decisions for chronic hepatitis B patients in different stages – A case-based approach
Speaker: Pietro Lampertico (Milan, Italy), Jorg Petersen (Hamburg, Germany)

15.00-16.30 Alcoholic Liver Disease & Alcoholic Hepatitis
Chair: Ioan Sporea, Patrizia Burra

15.00-15.20 Alcoholic liver disease: clinical variants (ASH, steatosis, cirrhosis) & natural history
Zeno Sparchez, Cluj-Napoca, Romania

15.20-15.40 Clinical diagnosis and general assessment in alcoholic liver disease
Marcel Tantau, Cluj-Napoca, Romania

15.40-16.05 Assessment of severity and prognosis in alcoholic hepatitis: scoring systems and beyond
Jose Altamirano, Barcelona, Spain

16.05-16.30 Treatment of alcoholic liver disease & alcoholic hepatitis
Patrizia Burra, Padua, Italy

16.30-17.15 Satellite Symposium AbbVie
Challenges in treating my HCV patients
Speaker: Anca Trifan, Liana Gheorghe (Romania)

17.15-17.30 Coffee break and Poster Viewing

 17.30-18.30 Parallel Case-based Workshops

1. Viral hepatitis
Presenters: Mona Munteanu, Roxana Sirli, Alina Tantau
Chair: Mircea Grigorescu, Ciprian Brisc, Ferrucio Bonino

2. NAFLD/NASH and Alcoholic hepatitis
Presenters: Horia Stefanescu, Carmen Ester
Chair: Ioan Sporea, Vlad Ratziu, Jose Altamirano

3. Complications of liver cirrhosis
Presenters: Corina Angelescu, Corina Pop, Bogdan Procopet, Razvan Cerban
Chair: Cristian Gheorghe, Carol Stanciu, Dominique Valla

19.00 Presidential Dinner

29 April 2016

 8.00-8.30 Registration & Welcome

 8.30-10.00 NAFLD & NASH
Chair: Vlad Ratziu, Mona Munteanu

8.30-8.50 NAFLD & NASH : concept and spectrum
Dana Crisan, Cluj-Napoca, Romania

8.50-9.10 Diagnosis of NAFLD/NASH: non-invasive tools or under the microscope ?
Ioan Sporea, Timisoara, Romania

9.10-9.35 Current front line therapy for NAFLD/NASH
Vito Cicinnati, Muenster, Germany

9.40.00-10.00 NAFLD and NASH: Who are the patients at risk of disease progression and complications?
Carmen Fierbinteanu, Bucharest, Romania

10.00-10.30 Coffee Break and Poster Viewing

10.30-12.00 Managing Chronic Hepatitis C
Chair: Oliviu Pascu, Vito Cicinnati

10.30-10.50 Current therapeutic strategies in  genotype 1-infected patients: trials, guidelines and beyond
Adrian Goldis, Timisoara, Romania

10.50-11.15 The real world of HCV infection: From clinical trials to the patient realities
Liana Gheorghe, Bucharest, Romania

11.15-11.35 What happens with „cured” patients”?
Anca Trifan, Iasi, Romania

11.35-12.00 DAA therapy in peritransplant setting
Susanne Beckebaum, Muenster, Germany

 12.00-12.45 Satellite Symposium Gilead
Clinical experience with modern HCV therapies
Tarik Asselah , Hôpital Beaujon (Paris, France)

 13.00-14.00 Lunch

 14.00-15.30 Emerging therapies in hepatology
Chair: Jose Altamirano, Massimo Pinzani

14.00-14.30 New approaches for the treatment of hepatic encephalopathy
Rajiv Jalan, London, UK

14.30-15.00 Novel targeted therapy for hepatocellular carcinoma
Costica Aloman, Chicago, USA

15.00-15.30 New methodologies for the identification of targets for antifibrotic drugs for chronic liver diseases
Massimo Pinzani, London, UK

15.30-16.00 Coffee Break and Poster Viewing

16.00-17.30 Managing the „difficult-to-treat” cirrhotic patient
Chair: Dominique Valla, Costica Aloman

16.00-16.25 Management of refractory ascites and complications
Dominique Valla, Paris, France

16.25-16.50 Management of variceal bleeding
Markus Peck, Vienna, Austria

16.50-17.15 Management of hepatocellular carcinoma: towards  personalized  surveillance, diagnosis and treatment
Ferrucio Bonino, Pisa, Italy

17.15 Closing: Anca Trifan, Ioan Sporea

 

 

footer